Iminosugars past, present and future: Medicines for tomorrow

Drug Discovery Today

Volumn 16, Issue 3-4, 2011, Pages 107-118

  Horne, Graeme ^a   Wilson, Francis X ^a   Tinsley, Jon ^a   Williams, David H ^a   Storer, Richard ^a  

^a SUMMIT PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; ACICLOVIR; AFEGOSTAT; ANTINEOPLASTIC AGENT; AT 2220; C 2100; CASTANOSPERMINE; CASTANOSPERMINE 6 BUTYRATE; CYTARABINE; DAPAGLIFLOZIN; GD 0039; GEMCITABINE; IDOXURIDINE; IMINOSUGAR; ISOLAB; LAMIVUDINE; MIGALASTAT; MIGLITOL; MIGLUSTAT; PEGINTERFERON ALPHA; RIBAVIRIN; SMT 14224; SWAINSONINE; TRIFLURIDINE; UNCLASSIFIED DRUG; VIDARABINE;

ABDOMINAL PAIN; ADVANCED CANCER; ADVERSE OUTCOME; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; CANCER THERAPY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIARRHEA; DRUG EFFICACY; DRUG MARKETING; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TOLERABILITY; FABRY DISEASE; FLATULENCE; GAUCHER DISEASE; GLYCOGEN STORAGE DISEASE TYPE 2; HEPATITIS C; HUMAN; IMMUNOMODULATION; LIVER TOXICITY; MELANOMA; NIEMANN PICK DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; UNSPECIFIED SIDE EFFECT;

DRUG DISCOVERY; IMINO SUGARS; MOLECULAR STRUCTURE; PHYSICOCHEMICAL PHENOMENA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79851508769     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.08.017     Document Type: Review

References (109)

1. A.E. Stuetz, Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond 1999 Wiley-VCH Verlag GmbH
2. P. Compain, O.R. Martin, Iminosugars: From Synthesis to Therapeutic Applications 2007 John Wiley and Sons Ltd.
3. H.R. Mellor Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphing (Pubitemid 39120497)
4. T.M. Cox Medicinal use of iminosugars P. Compain, O.R. Martin, Iminosugars: From Synthesis to Therapeutic Applications 2007 John Wiley and Sons Ltd. 295 326
5. B.G. Winchester Iminosugars: from botanical curiosities to licensed drugs Tetrahedron Asymmetry 20 2009 645 651
6. D. D'Alonzo Glycomimetics at the mirror: medicinal chemistry of L-iminosugars Curr. Med. Chem. 16 2009 473 505
7. N. Asano Naturally occurring iminosugars and related compounds: structure, distribution, and biological activity Curr. Top. Med. Chem. 3 2003 471 484
8. A. Kato Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids from Hyacinthoides non-scripta and Scilla campanulata Carbohydr. Res. 316 1999 95 103 (Pubitemid 29289986)
9. A. Kato Iminosugars from Baphia nitida Lodd Phytochemistry 69 2008 1261 1265
10. S. Inoue The structure of nojirimycin, a piperidinose sugar antibiotic J. Antibiotics Ser. A 19 1966 288 292
11. H. Umezawa Purification and characterization of a sialidase inhibitor, siastatin, produced by Streptomyces J. Antibiot. (Tokyo) 27 1974 963 969
12. A.A. Watson Polyhydroxylated alkaloids: natural occurrence and therapeutic applications Phytochemistry 56 2001 265 295 (Pubitemid 32162799)
13. A.A. Watson Water soluble bioactive alkaloids Spec. Publ. R. Soc. Chem. 257 2000 169 204
14. J.R. Jacob Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins J. Microbiol. 45 2007 431 440 (Pubitemid 350023378)
15. N. Asano Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.) J. Agric. Food Chem. 49 2001 4208 4213 (Pubitemid 32896411)
16. G.W.J. Fleet Inhibition of HIV replication by amino-sugar derivatives FEBS Lett. 237 1988 128 132
17. R.A. Gruters Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase Nature 330 1987 74 77 (Pubitemid 17152418)
18. M.J. Humphries Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors Cancer Res. 46 1986 5215 5222 (Pubitemid 16008292)
19. H. Moriyama Aza-sugar-based MMP/ADAM inhibitors as antipsoriatic agents J. Med. Chem. 47 2004 1930 1938 (Pubitemid 38453912)
20. L.G. Monovich Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13 J. Med. Chem. 52 2009 3523 3538
21. G.A. Kicska Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum J. Biol. Chem. 277 2002 3219 3225 (Pubitemid 34953184)
22. J. Liu Hexosaminidase inhibitors as new drug candidates for therapy of osteoarthritis Chem. Biol. 8 2001 701 711 (Pubitemid 32632536)
23. T. Latsis Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes Biochem. J. 368 2002 309 316 (Pubitemid 35463434)
24. P. Compain, and O.R. Martin Design, synthesis and biological evaluation of iminosugar-based glycosyltransferase inhibitors Curr. Top. Med. Chem. 3 2003 541 560
25. A.A. Voss Iminosugars are potent agonists of the human glucose sensor SGLT3 Mol. Pharmacol. 71 2007 628 634 (Pubitemid 46147927)
26. D. Brown RHS Encyclopedia of Herbs and Their Uses 2003 Dorling Kindersley
27. H.P. Broquist Identification of swainsonine as a probable contributory mycotoxin in moldy forage mycotoxicoses Appl. Environ. Microbiol. 48 1984 386 388 (Pubitemid 14068434)
28. A.D. Elbein Swainsonine: an inhibitor of glycoprotein processing Proc. Natl. Acad. Sci. U. S. A. 78 1981 7393 7397 (Pubitemid 12186147)
29. G.A. Bjarnason GD0039 in solid tumors Proc. Am. Soc. Clin. Oncol. 21 2002 2494
30. L.A. Sorbera Miglustat Drugs Future 28 2003 229 236
31. C. Dulsat, and N. Mealy Gaucher's disease Drugs Future 34 2009 147 149
32. J.E. Wraith, and J. Imrie New therapies in the management of Niemann-Pick type C disease: clinical utility of Miglustat Ther. Clin. Risk Manage. 5 2009 877 887
33. A.T. van der Ploeg, and A.J.J. Reuser Pompe's disease Lancet 373 2008 1342 1353
34. J.-Q. Fan Iminosugars as active-site specific chaperones for the treatment of lysosomal storage disorders Abstracts of Papers 230th ACS National Meeting, CARB-033 2005
35. J.-Q. Fan Iminosugars as active-site specific chaperones for the treatment of lysosomal storage disorders P. Compain, O.R. Martin, Iminosugars: From Synthesis to Therapeutic Applications 2007 John Wiley and Sons Ltd. pp. 225-247
36. G.-N. Wang Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease J. Med. Chem. 52 2009 3146 3149
37. G. Parenti Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease Mol. Ther. 15 2007 508 514
38. C. Dulsat, and N. Mealy Isofagomine tartrate: glycogen phosphorylase inhibitor treatment of Gaucher's disease Drugs Future 34 2009 23 25
39. Y.A. Zarate, and R.J. Hopkin Fabry's disease Lancet 372 2008 1427 1435
40. K. Sugawara Molecular interaction of imino sugars with human alpha-galactosidase: insights into the mechanism of complex formation and pharmacological chaperone action in Fabry disease Mol. Genet. Metab. 96 2009 233 238
41. R. Kornfeld, and S. Kornfeld Assembly of asparagine-linked oligosaccharides Annu. Rev. Biochem. 54 1985 631 664 (Pubitemid 15073660)
42. L.A. Sorbera Celgosivir Drugs Future 30 2005 545 552
43. A. Choukhi Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins J. Virol. 72 1998 3851 3858 (Pubitemid 28188685)
44. D. Durantel Celgosivir, an α-glucosidase I inhibitor for the potential treatment of hepatitis C virus infection Curr. Opin. Invest. Drugs. 10 2009 860 870
45. T.S. Mansour, and R. Storer Antiviral nucleosides Curr. Pharm. Des. 3 1997 227 264 (Pubitemid 27272429)
46. S. Cren A rapid synthesis of hexofuranose-like iminosugars using ring-closing metastasis Org. Lett. 7 2005 3521 3523 (Pubitemid 41186821)
47. L. Zhang Rapid synthesis of iminosugar derivatives for cell-based in situ screening discovery of "hit" compounds with anticancer activity ChemMedChem 2 2007 1594 1597
48. T. Jensen A concise synthesis of castanospermine by the use of a transannular cyclization J. Org. Chem. 74 2009 8886 8889
49. D. Best Looking glass inhibitors: scalable syntheses of DNJ, DMDP, and (3R)-3-hydroxy-l-bulgecinine from d-glucuronolactone and of l-DNJ, l-DMDP, and (3S)-3-hydroxy-d-bulgecinine from l-glucuronolactone. DMDP inhibits β-glucosidases and β-galactosidases whereas l-DMDP is a potent and specific inhibitor of α-glucosidases Tetrahedron Asymmetry 21 2010 311 319
50. A.C. Weymouth-Wilson Large scale synthesis of the acetonides of l-glucuronolactone and of l-glucose: easy access to l-sugar chirons Tetrahedron Lett. 50 2009 6307 6310
51. B.L. Stocker Recent Developments in the synthesis of pyrrolidine- containing iminosugars Eur. J. Org. Chem. 2010 1615 1637
52. P. Compain Tactics and strategies for the synthesis of iminosugar C-glycosides: a review Tetrahedron Asymmetry 20 2009 672 711
53. S.E. Denmark, and A.R. Hurd Synthesis of (+)-casuarine J. Org. Chem. 65 2000 2875 2886 (Pubitemid 30329143)
54. A.L. Concia D-Fructose-6-phosphate aldolase in organic synthesis: cascade chemical-enzymatic preparation of sugar-related polyhydroxylated compounds Chem. Eur. J. 15 2009 3808 3816
55. G. Lesma A chemoenzymatic-RCM strategy for the enantioselective synthesis of new dihydroxylated 5-hydroxymethyl indolizidines and 6-hydroxymethyl- quinolizidines Tetrahedron Asymmetry 18 2007 1948 1954 (Pubitemid 47385163)
56. T.J. Donohoe Synthesis of (+)-DGDP and (-)-7-epialexine Org. Biomol. Chem. 6 2008 3896 3898
57. S.G. Davies Iodine-mediated ring-closing iodoamination with concomitant N-debenzylation for the asymmetric synthesis of polyhydroxylated pyrrolidines Tetrahedron Asymmetry 20 2009 758 772
58. J.A. Coral De novo asymmetric approach to 8a-epi-swainsonine Heterocycles 79 2009 521 529
59. G.W.J. Fleet Enantiospecific synthesis of swainsonine, (1S, 2R, 8R, 8aR)-1,2,8-trihydroxyoctahydroindolizine, from d-mannose Tetrahedron Lett. 25 1984 1853 1856
60. G. Heimgartner Stereoselective synthesis of swainsonines from pyridines Tetrahedron 61 2005 643 655 (Pubitemid 39602825)
61. W.H. Pearson A synthesis of (1S, 2R, 8R, 8aR)-8-hydroxy-1,2- (isopropylidenedioxy)indolizin-5-one from d-ribose: improved access to (-)-swainsonine and its analogs Heterocycles 58 2002 421 430
62. P.K. Sharma Scale-up synthesis of swainsonine: a potent alpha-mannosidase II inhibitor Org. Process Res. Dev. 12 2008 831 836
63. Y. Ide Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-Iva and b) in pancreatic cancer Biochem. Biophys. Res. Commun. 341 2006 478 482 (Pubitemid 43152129)
64. L.M. Reis Mutation analysis of B3GALTL in Peters Plus syndrome Am. J. Med. Genet. A 146A 2008 2603 2610
65. S. Mondal Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric leukemia Leuk. Res. 34 2010 463 470
66. N. Takahashi High expression of N-acetylglucosaminyltransferase V in mucinous tumors of the ovary Oncol. Rep. 22 2009 1027 1032
67. Z. Zhang Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth Biochim. Biophys. Acta 1783 2008 287 296
68. J. Katrlik Glycan and lectin microarrays for glycomics and medicinal applications Med. Res. Rev. 30 2010 394 418
69. C.H. Liang, and C.Y. Wu Glycan array: a powerful tool for glycomics studies Exp. Rev. Proteom. 6 2009 631 645
70. D. Vanderschaeghe Glycome profiling using modern glycomics technology: technical aspects and applications Biol. Chem. 391 2010 149 161
71. A. Treiber The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor Miglustat in the rat Xenobiotica 37 2007 298 314 (Pubitemid 46439676)
72. R.H. Lachmann Miglustat: Substrate reduction therapy for glycoshingolipid lysosomal storage disorders Drugs Today (Barc) 42 2006 29 38
73. I. Izquierdo Polyhydroxylated pyrrolizidines. Part 6: a new and concise stereoselective synthesis of (+)-casuarine and its 6,7-diepi isomer, from DMDP Tetrahedron 61 2005 6527 6533 (Pubitemid 40812953)
74. M.-Y. Chang Synthesis of DMJ analogs with seven- and eight-membered iminocyclitols Tetrahedron 63 2006 1339 1344 (Pubitemid 44969426)
75. Y. Blériot Looking glass inhibitors: efficient synthesis and biological evaluation of d-deoxyfuconojirimycin Carbohydr. Res. 340 2005 2713 2718 (Pubitemid 41735357)
76. N. Asano Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases J. Med. Chem. 41 1998 2565 2571 (Pubitemid 28321905)
77. G.W.J. Fleet Synthesis of deoxymannojirimycin, fagomine, and deoxynojirimycin, 2-acetamido-1,5-imino-1,2,5-trideoxy-d-mannitol, 2-acetamido-1,5-imino-1,2,5-trideoxy-d-glucitol, 2S, 3R, 4R, 5R-trihydroxypipecolic acid and 2S, 3R, 4R, 5S-trihydroxypipecolic acid from methyl 3-O-benzyl-2,6-dideoxy-2,6-imino-alpha-d-mannofuranoside Tetrahedron 43 1987 979 990 (Pubitemid 17039614)
78. A.E. Hakansson Synthesis of the naringinase inhibitors l-swainsonine and related 6-C-methyl-l-swainsonine analogues: (6R)-C-methyl-l-swainsonine is a more potent inhibitor of l-rhamnosidase by an order of magnitude than l-swainsonine Tetrahedron Lett. 49 2007 179 184 (Pubitemid 350199553)
79. A.E. Hakansson Looking glass inhibitors: synthesis of a potent naringinase inhibitor l-DIM [1,4-dideoxy-1,4-imino-l-mannitol], the enantiomer of DIM [1,4-dideoxy-1,4-imino-d-mannitol] a potent alpha-d-mannosidase inhibitor Tetrahedron Asymmetry 18 2007 282 289
80. P.-H. Liang Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis ChemBioChem 7 2006 165 173 (Pubitemid 43076300)
81. L. Cipolla Combinatorial approaches to iminosugars as glycosidase and glycosyl-transferase inhibitors Comb. Chem. High Throughput Screen. 9 2006 571 582 (Pubitemid 44320406)
82. T.M. Chapman Glyco- and peptidomimetics from three-component Joullie-Ugi coupling show selective antiviral activity J. Am. Chem. Soc. 127 2005 506 507 (Pubitemid 40174360)
83. A. Lohse The first combinatorial library of azasugar glycosidase inhibitors Tetrahedron Lett. 40 1999 3033 3036 (Pubitemid 29156632)
84. L. Zhang Rapid synthesis of iminosugar derivatives for cell-based in situ screening: discovery of "hit" compounds with anticancer activity ChemMedChem 2 2007 1594 1597
85. P.V. Murphy, and J.L. Dunne Syntheses of peptidomimetics based on pyranose and poly-hydroxylated piperidine scaffolds Curr. Org. Synth. 3 2006 403 437 (Pubitemid 44697179)
86. B. La Ferla General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries P. Compain, O.R. Martin, Iminosugars: From Synthesis to Therapeutic Applications 2007 John Wiley and Sons Ltd. 25 61
87. D.B. Wertz Exploring the structural diversity of mammalian carbohydrates ("Glycospace") by statistical databank analysis ACS Chem. Biol. 10 2007 685 691
88. R.D. Cummings The repertoire of glycan determinants in the human glycome Mol. Biosyst. 5 2009 1087 1104
89. T.W. Rademacher Glycobiology Annu. Rev. Biochem. 57 1988 785 838
90. A. Varki Biological roles of oligosaccharides: all of the theories are correct Glycobiology 3 1993 97 130 (Pubitemid 23132602)
91. R.A. Dwek Glycobiology: toward understanding the function of sugars Chem. Rev. 96 1996 683 720 (Pubitemid 126649163)
92. R.G. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds Glycobiology 12 2002 43R 56R (Pubitemid 34760066)
93. H.H. Freeze Genetic defects in the human glycome Nat. Rev. Genet. 7 2006 537 551 (Pubitemid 43943571)
94. K. Ohtsubo, and J.D. Marth Glycosylation in cellular mechanisms of health and disease Cell 126 2006 855 867 (Pubitemid 44310784)
95. A. Varki, Essentials of Glycobiology second edition 2009 Cold Spring Harbor Laboratory Press
96. L.L. Kiessling, and R.A. Splain Chemical approaches to glycobiology Annu. Rev. Biochem. 79 2010 619 653
97. S. Griffin Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel Hepatology 48 2008 1779 1790
98. J. Chang Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses Antimicrob. Agents Chemother. 53 2009 1501 1508
99. S. Pollock N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery AIDS 22 2008 1961 1969
100. D. Best Cystic fibrosis and diabetes: isoLAB and isoDAB, enantiomeric carbon branched pyrrolidine iminosugars Tetrahedron Lett. 51 2010 4170 4174
101. H. Fiaux Functionalised pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site Bioorg. Med. Chem. 16 2008 7337 7346
102. Y. Chikaraishi CB-12181, a new azasugar-based matrix metalloproteinase/ tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo Curr. Neurovasc. Res. 6 2009 140 147
103. T. Wennekes Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation J. Med. Chem. 53 2010 689 698
104. F. Bietrix Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits athersclerosis development in APOE*3 Leiden and low-density lipoprotein receptor -/- mice Arterioscler. Thromb. Vasc. Biol. 30 2010 931 937
105. R.A. Clynes Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets Nat. Med. 6 2000 443 446 (Pubitemid 30208162)
106. T.M. Block Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin Proc. Natl. Acad. Sci. U. S. A. 91 1994 2235
107. A. Mehta Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications Hepatology 33 2001 1488 1495 (Pubitemid 32496986)
108. WHO Report (2004) The molecular genetic epidemiology of cystic fibrosis.
109. B. Lubamba Airway delivery of low-dose Miglustat normalizes nasal potential difference in F508del cystic fibrosis mice Am. J. Respir. Crit. Care Med. 179 2009 1022 1028